You are receiving this message since your browser does not support Java Script or you have Java Scripts disabled. The following disclaimer is provided as an alternative to the information that would normally be seen on your monitor when you click on a link to a non-federal site.

"You are now leaving the NIDDK website. The NIDDK is not responsible for the content of web pages found on this linked website. Links to nonfederal organizations are provided solely as a service to our users. These links do not indicate an endorsement of these organizations by NIDDK or the federal government."

Type 1 Diabetes Research

Research Funding Opportunities and Other Research Support Opportunities - Current and Upcoming*

View archived research funding opportunities.

Current



  • Request for Proposals: Islet Cell Distribution Coordinating Center
    NIH-NIDDK-08-099-SB
    Due date: 3:00 EST on February 11, 2009


  • Type 1 Diabetes TrialNet: Clinical Centers (U01)
    RFA-DK-08-011
    Release Date: December 24, 2008
    Letters of Intent Receipt Date: February 10, 2009
    Application Receipt Date: March 10, 2009


  • Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas (SBIR) [R43/R44])
    RFA-DK-09-001
    Release/Posted Date: December 10, 2008
    Opening Date: March 15, 2009 (Earliest date an application may be submitted to Grants.gov)
    Letters of Intent Receipt Date: March 16, 2009
    Application Receipt Date: April 15, 2009


  • Innovative Patient Outreach Programs and Ocular Screening Technologies to Improve Detection of Diabetic Retinopathy (SBIR [R43/R44])
    RFA-EY-09-001
    Release/Posted Date: December 9, 2008
    Opening Date: February 23, 2009 (Earliest date an application may be submitted to Grants.gov)
    Application Due Date(s): March 23, 2009; December 23, 2009


  • Closed Loop Technologies: Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R01)
    RFA-DK-08-012
    Release/Posted Date: November 28, 2008
    Opening Date: February 19, 2009 (Earliest date an application may be submitted to Grants.gov)
    Letters of Intent Receipt Date: February 19, 2009
    Application Receipt Date: March 19, 2009


  • Closed Loop Technologies: Pilot and Exploratory Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R21)
    RFA-DK-08-013
    Release/Posted Date: November 28, 2008
    Opening Date: February 19, 2009 (Earliest date an application may be submitted to Grants.gov)
    Letters of Intent Receipt Date: February 19, 2009
    Application Receipt Date: March 19, 2009


  • Fine Mapping and Function of Genes for Type 1 Diabetes (DP3)
    RFA-DK-08-006
    Release Date: October 16, 2008
    Opening Date: February 27, 2009 (Earliest date an application may be submitted to Grants.gov)
    Letters of Intent Receipt Date: February 27, 2009
    Application Receipt Date: March 30, 2009


  • Seeding Collaborative Research in Beta Cell Biology (SCRBCB) Program
    www.betacell.org/seeding/
    This program will provide research support for a limited time (18 months) to enable eligible investigative teams to explore the feasibility of concepts related to the mission of the Beta Cell Biology Consortium. Specific details can be found on the BCBC website at www.betacell.org/seeding/. Research areas open to support through the SCRBCB program are:
    • Generation of humanized mouse models for the assessment and enhancement of human islet regenerative capacity.
    • Production and use of T1D-specific induced pluripotent stem cells (iPSCs).
    • Transdifferentiation or reprogramming of a differentiated cell type into a pancreatic beta-cell.
    • Generation of engineered pancreatic islet-like structures for engraftment.
    • Non-invasive technology for imaging of beta-cell mass in vivo.
  • Request for Information. Agents to be tested for Preclinical Efficacy in Prevention or Reversal of Type 1 Diabetes in Rodent Models. Type 1 Diabetes Preclinical Testing Program (T1D-PTP)
    NOT-DK-08-012

  • Request for Information. Agents to be tested for Preclinical Efficacy in Prevention or Reversal of Type 1 Diabetes in Rodent Models. Preclinical Testing for the Type 1 Diabetes Rapid Access to Intervention Development (T1D-RAID) Program
    NOT-DK-07-009

  • Request for Information. Testing for Preclinical Efficacy in Prevention or Reversal of Diabetic Complications in Rodent Models
    NOT-DK-07-013

Back to Opportunities Page

Upcoming


  • None at this time.

Back to Opportunities Page

*These opportunities are supported in whole or in part by the Special Statutory Funding Program for Type 1 Diabetes Research.
Last Updated: 12/30/2008

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583